MGB Biopharma succeeds in developing an IV formulation of MGB-BP-3 for the treatment of hospital-acquired infections
2 June 2015 | By Victoria White
MGB Biopharma has developed a stable IV formulation of MGB-BP-3 for the treatment of Gram-positive hospital-acquired infections...